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Ion channel proteins are required for both the establishment of resting membrane potentials and the generation of action potentials.
Hundreds of mutations in genes encoding voltage-gated ion channels responsible for action potential generation have been found to
cause severe neurological diseases. In contrast, the roles of voltage-independent ‘‘leak’’ channels, important for the establishment
andmaintenance of restingmembrane potentials uponwhich action potentials are generated, are not well established in human disease.
UNC80 is a large component of the NALCN sodium-leak channel complex that regulates the basal excitability of the nervous system.
Loss-of-function mutations of NALCN cause infantile hypotonia with psychomotor retardation and characteristic facies (IHPRF). We
report four individuals from three unrelated families who have homozygous missense or compound heterozygous truncating mutations
in UNC80 and persistent hypotonia, encephalopathy, growth failure, and severe intellectual disability. Compared to control cells,
HEK293T cells transfected with an expression plasmid containing the c.5098C>T (p.Pro1700Ser) UNC80 mutation found in one indi-
vidual showed markedly decreased NALCN channel currents. Our findings demonstrate the fundamental significance of UNC80 and
basal ionic conductance to human health.Among mammalian neurons from different brain regions,
there is considerable variability in basal excitability
and resting membrane potentials (from approximately
85 mV to 50 mV) upon which action potentials are
generated. Many mutations in voltage-gated ion channels
responsible for the generation of action potentials have
been found to cause severe diseases, including migraine,
episodicmuscle paralysis, ataxia, epilepsy, autism, and sud-
den cardiac death (see Jurkat-Rott et al., Kullmann and
Waxman, and Catterall et al.1–3 for reviews). In contrast,
the molecular mechanisms and the role of basal excit-
ability in human diseases are not well understood.
The resting membrane potential is primarily determined
by ion channels that are open and ‘‘leaky’’ at rest. The
basal Naþ leak is mainly established through the NALCN
Naþ-leak channel. In mouse hippocampal neurons,
NALCN is responsible for ~70% of the total basal Naþ
leak.4 NALCN is a member of the 24-transmembrane
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nels.5 It forms a voltage-independent, Naþ-permeable,
non-selective, non-inactivating cation channel. NALCN’s
unique properties allow it to generate background so-
dium-leak currents. The balance between Naþ influx
through NALCN and Kþ efflux through other channels is
predicted to generate a large dynamic range of neuronal
excitability. In mammalian brains, the NALCN complex
also contains UNC79 and UNC80, homologs of C. elegans
Unc-79 and Unc-80.6–8 In situ hybridization analysis,
RNA sequencing (RNA-seq), and expression sequence-tag
(EST) database searches suggest that NALCN (MIM:
611549), UNC79, and UNC80 (MIM: 612636) are widely
expressed in the brain.4 Both UNC79 and UNC80 are large
proteins (~3,000 amino acids) but do not have recogniz-
able domains. NALCN and UNC79 do not directly interact
with each other; the three components are brought
together by UNC80’s association with both UNC79 and
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Table 1. Clinical Characteristics of Individuals with UNC80 Mutations
Subject
Family 1 Family 2 Family 3
IV.1 V.5 II.1 II.3
Age at last review 4 years 4 years 15 years 9 years
Gender female female female female
Country of parental origin Iraq Morocco Norway Norway
Parental consanguinity þ þ  
Gestational age 41 weeks 41 weeks 38 weeks 40 weeks
Birth weight (percentile) 3,000 g (25th) 3,158 g (50th) 2,960 g (25th) 3,070 g (25th)
OFC at birth (percentile) 33 cm (25th) unavailable 32 cm (10th) 35 cm (75th)
Hypotonia first noted birth birth birth 3 months
Persistent hypotonia þ þ þ þ
Feeding difficulties þ þ  þ
Age at G-tube insertion
(degree of dependency)
2 years (dependent) 3.5 years (dependent) 15 years (supplemental
use)
10 months (completely
dependent)
Current age 4 years 4 years 15 years 10 years
Current height
(percentile)
72 cm (<<3rd) 91.5 cm (<3rd) 144 cm (<<3rd) 125 cm (3rd)a
Current weight (BMI) 7.4 kg (14.3) 12.9 kg (15.4) 40.2 kg (17) 23.5 kg (15.7)a
Current OFC (percentile) 43 cm (<<3rd, or 4 SD) 47 cm (2nd, or 1 SD) 51.5 cm (3rd) 50.5 cm (10th)a
Ophthalmology punctate keratopathy,
normal visual evoked
potentials
alternating esotropia,
normal visual evoked
potentials
esotropia, normal vision esotropia, normal vision,
normal visual evoked
potentials
Hypotonic facies þ þ þ þ
Small hands and feet þ  þ þ
Severe global
developmental delay and
intellectual disability
þ þ þ þ
Communication no speech no speech no speech, babbles
socially, expressive body
language
no speech, babbles
socially, expressive body
language
Psychosocial poor eye contact, minimal
interest in surroundings
sociable, studies faces
with interest
sociable, content,
interested in
surroundings
sociable, content,
interested in
surroundings
Gross motor unable to sit, non-
ambulatory
sits without support, non-
ambulatory
sits with support, pulls to
stand, walks with a walker
sits without support,
stands and walks with
support
Fine motor transfers objects across
midline
brings food to mouth,
manipulates toys
brings food to mouth,
manipulates toys
Manipulates objects
Muscle weakness þ, MRC grade 3/5 difficult to assess due to
severe hypotonia
þ, MRC grade 4/5 þ, MRC grade 4/5
Seizures, age of onset þ, 3 months (none since 3
years old)
þ, 3 years and 10 months þ, 6 months þ, 3 years
Seizure types generalized tonic-clonic generalized tonic-clonic myoclonic, atonic,
generalized tonic-clonic,
atypical absences
atonic, atypical absences
Current anti-convulsive
therapy
clonazepam valproate, rivotril valproate, lamotrigine,
levetiracetam, vagal nerve
stimulator
valproate
Severe constipation þ þ þ þ
Tactile aversion   þ þ
(Continued on next page)
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Table 1. Continued
Subject
Family 1 Family 2 Family 3
IV.1 V.5 II.1 II.3
Hypersensitivity for
stimuli
 þ þ þ
Sleep disturbance þ, obstructive sleep apnea þ  
Brain MRI thin corpus callosum no structural anomalies no structural anomalies no structural anomalies
EEG encephalopathic
background with
occasional spike and wave
discharges
encephalopathic
background pattern with
frequent multifocal
discharges
encephalopathic
background activity with
frequent spike and wave
discharges
encephalopathic
background activity with
frequent spike and wave
discharges
Other non-specific myopathic
changes on muscle biopsy
not reported mild scoliosis, euthyroid milk protein intolerance
in infancy, euthyroid
Mutationb chr2:210783340C>T chr2:210824431G>C chr2:210832310T>A chr2:210685105delA
UNC80 (GenBank:
NM_032504.1)
c.5098C>T c.7607G>C c.7757T>A c.2033delA
Exon number 32 50 51 13
Predicted effect on
protein
p.Pro1700Ser p.Arg2536Thr, predicted
to cause aberrant splicing
p. Leu2586* p.Asn678Thrfs*15
Type of mutation missense missense stop frameshift insertion
Abbreviations are as follows: þ, present; , not present; OFC, occipital frontal circumference; MRC, Medical Research Council scale for muscle strength.
aMeasurements for individual II.3 were taken at the last examination at the age of 9 years, rather than at the current age.
bBased on UCSC Genome Browser GRCh37.by extracellular Ca2þ through a G-protein-dependent
pathway and by neuropeptides, such as substance P,
through a G-protein-independent pathway that also re-
quires the Src family of kinases.5
In worms and flies, mutations inNalcn, Unc-79, and Unc-
80 lead to uncoordinated movements, abnormal circadian
rhythms, and altered sensitivity to anesthetics.9–13 In
mice, knocking out Nalcn or Unc79 leads to severe apnea
and neonatal lethality.4,5,7 In humans, inherited homozy-
gous loss-of-function NALCN mutations cause infantile
hypotonia with psychomotor retardation and character-
istic facies (IHPRF [MIM: 615419]).14,15 De novo heterozy-
gous NALCN mutations are also found in individuals with
arthrogryposis, hypotonia, intellectual disability, and
developmental delay.16,17
Despite its widespread expression in the brain, the
in vivo function of UNC80 is largely unknown, and nomu-
tations in mammals have been reported. We report the
identification and characterization of UNC80 mutations
as the cause of severe neurological phenotypes in four fe-
male individuals from three unrelated families.
The four subjects have similar phenotypes characterized
by severe hypotonia of neonatal onset and that persists
until adolescence, motor delays, lack of independent
ambulation, constipation, encephalopathy, seizures, ab-
sent speech, and severe intellectual disability. The clinical
features and genetic results of all subjects are summarized
in Table 1 and Figure 1. Research protocols were approved
in each country via institutional research boards and
regional ethics committees, in keeping with national
guidelines and the principles laid out in the Declaration204 The American Journal of Human Genetics 98, 202–209, January 7of Helsinki. For the Norwegian family (F3), molecular ana-
lyses were performed in accordance with the Norwegian
National Biotechnology Act. All parents provided written
informed consent for study participation for themselves
and their children, as well as for publication of clinical in-
formation, molecular findings, and photographs.
For family 1, the whole-exome sequencing (WES) library
preparation, exon capture, and sequencing were per-
formed at the Genome Que´bec Innovation Center (Mon-
tre´al) as previously described.18 Genomic DNA was
captured with the SureSelect Human 50 Mb All Exon V5
kit (Agilent Technologies). Sequencing was performed on
an Illumina HiSeq 2000 (Illumina) with paired-end
100-bp reads. A mean coverage of 1343 was obtained,
and 97% of the bases were covered at more than 103.
WES trio average coverage was 553. Read alignment,
variant calling, and annotation were done with a pipeline
based on the Burrows-Wheeler Aligner (BWA), SAMtools,
ANNOVAR, and custom annotation scripts, and reads
were aligned to the reference human genome (UCSC
Genome Browser hg19).
For family 2, DNA capture was performed with the
SeqCap EZ Exome v.3.0 (Roche Nimblegen). Sequencing
was performed on an Illumina HiSeq 2000 (Illumina)
with paired-end 100-bp reads. A mean coverage of 763
was obtained, and 94% of the bases were covered at more
than 103. Read alignment to the reference human genome
(hg19) and variant calling were done with a pipeline based
on BWA-MEM v.0.7 and the Genome Analysis Toolkit
(GATK v.3.1-1-g07a4bf8). Variant annotation and priori-
tizing were done with Cartagenia NGS Bench (Cartagenia)., 2016
Figure 1. Clinical Photographs of All Four Subjects
(A) Subject F1-IV.1 at the age of 4 years.
(B) Subject F2-V.5 at the age of 3 years.
(C) Subject F3-II.1 at the age of 9 years.
(D) Subject F3-II.3 at the age of 3 years.Four individuals from family 3 were tested and included
in the Center for Mendelian Genomics project at the Bay-
lor College of Medicine (BCM) in Houston, Texas. TheThe AmerWES method used at the BCM-HGSC (Human Genome
Sequencing Center) has previously been described.19 In
brief, DNA was prepared for Illumina paired-end libraries,
and capture was performed with the in-house-developed
BCM-HGSC Core design and sequenced on the Illumina
HiSeq 2500 platform (Illumina). Data produced was
processed through the HGSC-developed Mercury pipe-
line, available in the cloud,20 to produce variant call
format files (.vcf) with the Atlas2 variant calling
method.21–23 Variants were annotated with the in-house-
developed ‘‘Cassandra’’24 annotation pipeline, based on
ANNOVAR.25 Variants of interest were selected on the
basis of inheritance pattern, rarity, and evaluation of
possible genotype-phenotype correlation by knowledge
of gene function, pathway, expression pattern, and results
from other model organisms. Alamut v.2.4.6 (Interactive
Biosoftware) was used in evaluation of pathological rele-
vance. Additional support was sought by application of
computational prediction tools (PhyloP, SIFT, PolyPhen-2,
LRT, and MutationTaster). All UNC80 variants were
confirmed by Sanger sequencing. Unaffected family mem-
bers were also Sanger sequenced to confirm that the
variant segregated with disease. Sanger sequencing was
performed on genomic DNA from peripheral blood.
Primers for Sanger sequencing were designed with Primer3
software and sequenced on an ABI 3730 sequencer
(Applied Biosystems, Life Technologies), and sequence
data was analyzed with SeqScape v.2.7 (Life Technologies)
and 4Peaks.
Subject F1-IV.1 was found to be homozygous for a
c.5098C>T missense variant (p.Pro1700Ser) in exon 32
of UNC80 (GenBank: NM_032504.1). The variant is pre-
dicted to be deleterious and is present at a position
completely conserved among all animals (Figure S3). The
subject’s father was unable to be tested, but her mother
was confirmed to be a carrier of the variant (Figure 2).Figure 2. Pedigrees and Chromatograms
from All Three Families
Affected individuals are shaded in black.
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AB
Figure 3. Variant UNC80 Associates with UNC79 and NALCN
(A) Cells were transfected with UNC79 alone or together with WT
or variant Unc80 as indicated in each lane. Immunoprecipitates
(IP) with an anti-UNC80 antibody were blotted (IB) with anti-
UNC79 to allow us to probe the association between UNC79
and UNC80 (upper panel). Total cell lysates (lower three panels)
were blotted with anti-UNC79 or anti-UNC80 antibodies for com-
parison of protein amounts. Immunoblotting with anti-b-actin
(lower panel) was used as a control for sample loading.
(B) Cells were transfected with FLAG-tagged NALCN alone or
together with the WT or variant Unc80, as indicated. Immunopre-
cipitates with anti-FLAGwere blotted with anti-UNC80 to allow us
to probe the association between UNC80 and NALCN. For immu-
noprecipitation, cells were solubilized in lysis buffer (50 mM
Tris-HCl, 150mMNaCl, 1%NP-40, 13 PIC [Roche]) and immuno-
precipitated with anti-UNC80 (2 mg/ml)7 or anti-FLAG (5 mg/ml,
no. F3165 [Sigma]). The immune complexes were analyzed
by western blot with anti-UNC80 (2.2 mg/ml) or anti-UNC79
(3 mg/ml). Cell lysates (inputs) were also analyzed by western
blot with anti-UNC80 or anti-b-actin (1:1,000, no. 4970S [Cell
Signaling]) as indicated.Subject F2-V.5 had a homozygous missense variant in
UNC80, c.7607G>C (p.Arg2536Thr). G7607 is the last
nucleotide of exon 50. The c.7607G>C variant disrupts
the ‘‘AG’’ exonic sequence commonly found in exon-
intron junctions upstream of the conserved splice-donor
sequence ‘‘GT.’’ The variant is predicted by five indepen-
dent methods to affect splicing efficiency (Figure S4).
Splicing studies of UNC80 were not performed because206 The American Journal of Human Genetics 98, 202–209, January 7UNC80 is not expressed in peripheral leukocytes and no
other tissue was available from this individual. The variant
(p.Arg2536Thr) is also predicted to neutralize a charged
residue highly conserved in all animals (Figure S5), sug-
gesting that the variant disrupts protein function even
in transcripts that are correctly spliced. Splicing analysis
in neurons and functional characterization of the corre-
sponding protein are required to determine the molecular
consequence of this variant. Both healthy parents of sub-
ject F2-V.5 were heterozygous carriers, and all four healthy
siblings were either heterozygous or bi-allelic wild-type
(WT) at this nucleotide position (Figure 2). Subject
F3-II.1 and subject F3-II.3 were both found to be
compound heterozygous for the following UNC80 vari-
ants: c.2033delA (p.Asn678Thrfs*15) and c.7757T>A
(p.Leu2586*) (GenBank: NM_032504.1). Both parents
were found to be heterozygous carriers of one of the vari-
ants (Figure 2). None of the variants were present in pub-
lically available databases (dbSNP, 1000 Genomes, and the
ExAC Browser), and the c.5098C>T variant was found in
the heterozygous state in one individual in the database
of over 3,000 exomes at the Center for Mendelian
Genomics.
The three mutations in subjects F2-V.5, F3-II.1, and F3-
II.3 are predicted to lead to disruption (in F2-V.5, due to
aberrant splicing) or truncation (in F3-II.1 and F3-II.3) of
UNC80 and are most likely loss-of-function mutations.
To determine whether the c.5098C>T missense variant
(p.Pro1700Ser) in subject F1-IV.1 affects expression and
function of UNC80, we introduced the variant into mouse
Unc80 cDNA, which encodes a protein with 97% identity
to the human UNC80 and has been functionally character-
ized. The mouse Unc80 cDNA (GenBank: FJ210934)
was cloned into the EcoRI and NotI sites of vector
pcDNA3.1. The p.Pro1769Ser variant (equivalent to hu-
man p.Pro1700Ser) was introduced with the Gibson assem-
bly method. The sequences of the primers used for muta-
genesis are as follows: 50-GTTCGACCCTCCGTGGGTCtCT
CAGTGCAGCGGGAGTG-30 (forward), 50-CACTCCCGCT
GCACTGAGAGACCCACGGAGGGTCGAAC-30 (reverse).
The mutation was confirmed with Sanger sequencing.
We transfected the WT and variant Unc80 into human
HEK293T cells (from ATCC, maintained in DMEM
[GIBCO] supplemented with 10% FBS [Atlanta Biologi-
cals] and 13 Glutamax [GIBCO]; transfection done with
Lipofectamine 2000 as the transfection reagent). The
Unc80 variant yielded an amount of protein comparable
to that yielded by the WT Unc80 (Figure 3A, lower two
panels), suggesting that this missense variant does not
disrupt production of the protein. The variant protein
also retained its ability to associate with UNC79
(Figure 3A) and NALCN (Figure 3B), which was tested by
co-immunoprecipitation.
We next used electrophysiological assays to test whether
the p.Pro1769Ser (mouse equivalent of p.Pro1700Ser)
variant affects the function of UNC80. A unique property
of UNC80 is its ability to scaffold Src kinase and to enhance, 2016
A B
C
Figure 4. Altered Function in Variant UNC80
(A and B) Representative NALCN currents recorded in HEK293T
cells co-transfected with NALCN and WT Unc80 (A) or the mutant
version of Unc80 (B). Whole-cell currents were recorded with a
voltage ramp from 100 mV to þ100 mV in 1 s (Vh ¼ 0 mV, illus-
trated in the lower panel of A). In cells with currents larger than
50 pA, NMDG was used to substitute Naþ and Kþ to confirm
that the cells had no non-specific leak, as demonstrated by the
abolishment of inward currents with ion substitution.
(C) Summary of the current amplitudes recorded at 100 mV.
Numbers of cells recorded are in parentheses. Data were presented
as mean5 SEM. *p < 0.05. ***p < 0.001. For patch clamp record-
ings, cells in a 35-mm dish (~90% confluency) were transfected
with 3 mg plasmids DNA with Lipofectamine 2000 for ~40 hr
and plated onto polylysine-coated coverslips. Recordings were
done 40–48 hr after transfection. Cells with GFP fluorescence in-
tensity within the top 20%–30% on each coverslip were selected
for patch clamp recordings. Signal was acquired with an amplifier
(Axopatch 200B or Multiclamp 700B) and a Digidata 1440A data
acquisition system controlled by PClamp software (Molecular De-
vice). The pipette solution contained 150 mM Cs, 120 mM Mes,
10 mM NaCl, 10 mM EGTA, 4 mM CaCl2, 0.3 mM Na2GTP,
2 mMMg-ATP, 10 mMHEPES and 2 mM Src family kinase activator
(pH 7.4; from Santa Cruz). Bath solutions contained 150 mM
NaCl, 3.5 mM KCl, 1 mMMgCl2, 1.2 mM CaCl2, 20 mM glucose,
and 10 mMHEPES (pH 7.4). In the NMDG bath, Naþ and Kþ were
replaced by NMDGþ. Liquid junction potentials were corrected
online.NALCN currents through a Src-dependent pathway.6,8 We
recorded NALCN currents from HEK293T cells that we co-
transfected with NALCN cDNA (human isoform,7 in a
pTracer vector expressing GFP under a separate promoter)
and WT or variant Unc80 by using patch clamp pipettes
containing a peptide Src activator (Figure 4A, lower panel).
Compared to those in cells transfected withWT Unc80, the
sizes of the currents were significantly reduced in cells ex-
pressing the variant (Figures 4B and 4C).
In summary, our studies reveal a genetic cause for global
developmental delay and neurological dysfunction and
demonstrate the importance of UNC80 in humans. From
a motor perspective, all four individuals were significantly
delayed in sitting; one individual was still unable to
achieve this at the age of 4 years. None of the individuals
were able to ambulate independently. These symptomsThe Amerare comparable with those observed in individuals with
loss-of-functionNALCNmutations.14,15 Unlike individuals
with NALCNmutations, our four UNC80 individuals show
no true facial dysmorphism, although their faces are char-
acterized by features related to severe hypotonia. All indi-
viduals in our study were described as encephalopathic,
both clinically and on electroencephalogram (EEG) moni-
toring. Growth failure, severe constipation, and the
feeding difficulties requiring G-tube insertion might be
due, in part, to dysfunctional muscle coordination via
neuronal compromise; however, standardized evaluation
of swallowing function for all individuals would be
required to confirm this. Subject F1-IV.1 also had severe
sleep disturbance, including complete reversal of her
sleep-wake cycle, which was resistant to treatment with
melatonin. Subject F2-V.5 also had sleep disturbance,
including difficulty falling asleep. In flies and mice,
NALCN is essential for the depolarization of clock neurons
in the morning and the maintenance of normal circadian
rhythms.26 It is possible that abnormal UNC80 prevents
activation of the NALCN complex and inhibits the ability
of pacemaker neurons to maintain basal sleep-wake
rhythm.
Compared to phenotypes associated with mutations
found in known neuronal genes, the neurological pheno-
types we describe in these four UNC80 individuals are at
the severe end of the spectrum. This underscores the
pivotal importance of leak ion channel genes and the asso-
ciated basal excitability in human health and disease.Supplemental Data
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